Literature DB >> 31209073

Bordetella bronchiseptica Diguanylate Cyclase BdcA Regulates Motility and Is Important for the Establishment of Respiratory Infection in Mice.

Keila Belhart1, María de la Paz Gutierrez1, Federico Zacca1, Nicolás Ambrosis1, Monica Cartelle Gestal2, Dawn Taylor2, Kurt M Dahlstrom3, Eric T Harvill2, George A O'Toole3, Federico Sisti4, Julieta Fernández4.   

Abstract

Bacteria can be motile and planktonic or, alternatively, sessile and participating in the biofilm mode of growth. The transition between these lifestyles can be regulated by a second messenger, cyclic dimeric GMP (c-di-GMP). High intracellular c-di-GMP concentration correlates with biofilm formation and motility inhibition in most bacteria, including Bordetella bronchiseptica, which causes respiratory tract infections in mammals and forms biofilms in infected mice. We previously described the diguanylate cyclase BdcA as involved in c-di-GMP synthesis and motility regulation in B. bronchiseptica; here, we further describe the mechanism whereby BdcA is able to regulate motility and biofilm formation. Amino acid replacement of GGDEF with GGAAF in BdcA is consistent with the conclusion that diguanylate cyclase activity is necessary for biofilm formation and motility regulation, although we were unable to confirm the stability of the mutant protein. In the absence of the bdcA gene, B. bronchiseptica showed enhanced motility, strengthening the hypothesis that BdcA regulates motility in B. bronchiseptica We showed that c-di-GMP-mediated motility inhibition involved regulation of flagellin expression, as high c-di-GMP levels achieved by expressing BdcA significantly reduced the level of flagellin protein. We also demonstrated that protein BB2109 is necessary for BdcA activity, motility inhibition, and biofilm formation. Finally, absence of the bdcA gene affected bacterial infection, implicating BdcA-regulated functions as important for bacterium-host interactions. This work supports the role of c-di-GMP in biofilm formation and motility regulation in B. bronchiseptica, as well as its impact on pathogenesis.IMPORTANCE Pathogenesis of Bordetella spp., like that of a number of other pathogens, involves biofilm formation. Biofilms increase tolerance to biotic and abiotic factors and are proposed as reservoirs of microbes for transmission to other organs (trachea, lungs) or other hosts. Bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) is a second messenger that regulates transition between biofilm and planktonic lifestyles. In Bordetella bronchiseptica, high c-di-GMP levels inhibit motility and favor biofilm formation. In the present work, we characterized a B. bronchiseptica diguanylate cyclase, BdcA, which regulates motility and biofilm formation and affects the ability of B. bronchiseptica to colonize the murine respiratory tract. These results provide us with a better understanding of how B. bronchiseptica can infect a host.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Bordetella; biofilm; c-di-GMP; motility

Mesh:

Substances:

Year:  2019        PMID: 31209073      PMCID: PMC6689298          DOI: 10.1128/JB.00011-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

Review 1.  Mechanisms of Bordetella pathogenesis.

Authors:  S Mattoo; A K Foreman-Wykert; P A Cotter; J F Miller
Journal:  Front Biosci       Date:  2001-11-01

2.  The PilZ domain is a receptor for the second messenger c-di-GMP: the PilZ domain protein YcgR controls motility in enterobacteria.

Authors:  Dmitri A Ryjenkov; Roger Simm; Ute Römling; Mark Gomelsky
Journal:  J Biol Chem       Date:  2006-08-18       Impact factor: 5.157

Review 3.  Get the message out: cyclic-Di-GMP regulates multiple levels of flagellum-based motility.

Authors:  Alan J Wolfe; Karen L Visick
Journal:  J Bacteriol       Date:  2007-11-09       Impact factor: 3.490

4.  Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli.

Authors:  G BERTANI
Journal:  J Bacteriol       Date:  1951-09       Impact factor: 3.490

5.  Constitutive expression of bvgR-repressed factors is not detrimental to the Bordetella bronchiseptica-host interaction.

Authors:  Julieta Fernández; Federico Sisti; Daniela Bottero; María Emilia Gaillard; Daniela Hozbor
Journal:  Res Microbiol       Date:  2005-09       Impact factor: 3.992

6.  The BvgAS signal transduction system regulates biofilm development in Bordetella.

Authors:  Meenu Mishra; Gina Parise; Kara D Jackson; Daniel J Wozniak; Rajendar Deora
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

7.  The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica.

Authors:  Yasuhiko Irie; Seema Mattoo; Ming H Yuk
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

8.  Determinants for the activation and autoinhibition of the diguanylate cyclase response regulator WspR.

Authors:  Nabanita De; Marcos V A S Navarro; Rahul V Raghavan; Holger Sondermann
Journal:  J Mol Biol       Date:  2009-08-18       Impact factor: 5.469

9.  In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.

Authors:  Gregory G Anderson; Sophie Moreau-Marquis; Bruce A Stanton; George A O'Toole
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

10.  The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract.

Authors:  Gina Parise Sloan; Cheraton F Love; Neelima Sukumar; Meenu Mishra; Rajendar Deora
Journal:  J Bacteriol       Date:  2007-06-22       Impact factor: 3.490

View more
  2 in total

1.  Cyclic di-GMP Regulates the Type III Secretion System and Virulence in Bordetella bronchiseptica.

Authors:  María de la Paz Gutierrez; Ting Y Wong; Fredrick Heath Damron; Julieta Fernández; Federico Sisti
Journal:  Infect Immun       Date:  2022-05-25       Impact factor: 3.609

2.  Outer Membrane Vesicles Coating Nano-Glycyrrhizic Acid Confers Protection Against Borderella bronchiseptica Through Th1/Th2/Th17 Responses.

Authors:  Yee Huang; Li Nan; Chenwen Xiao; Jie Dong; Ke Li; Jvfen Cheng; Quanan Ji; Qiang Wei; Guolian Bao; Yan Liu
Journal:  Int J Nanomedicine       Date:  2022-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.